Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,298.00 JPY | 0.00% | +0.48% | -2.00% |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 50.27B | 39.15B | 35.13B | 39.18B | 43.27B | |||||
Total Revenues | 50.27B | 39.15B | 35.13B | 39.18B | 43.27B | |||||
Cost of Goods Sold, Total | 43.84B | 38.26B | 32.96B | 34.11B | 36.64B | |||||
Gross Profit | 6.43B | 890M | 2.17B | 5.07B | 6.63B | |||||
Selling General & Admin Expenses, Total | 5.95B | 5.35B | 4.77B | 4.13B | 4.57B | |||||
Depreciation & Amortization - (IS) | 243M | 264M | 292M | 238M | 217M | |||||
Other Operating Expenses | 27M | 19M | 21M | 35M | 33M | |||||
Other Operating Expenses, Total | 6.22B | 5.63B | 5.08B | 4.4B | 4.82B | |||||
Operating Income | 210M | -4.74B | -2.91B | 666M | 1.82B | |||||
Interest Expense, Total | -208M | -221M | -211M | -187M | -183M | |||||
Interest And Investment Income | 49M | 47M | 40M | 53M | 42M | |||||
Net Interest Expenses | -159M | -174M | -171M | -134M | -141M | |||||
Income (Loss) On Equity Invest. | 12M | -22M | -14M | 12M | 100M | |||||
Currency Exchange Gains (Loss) | -27M | -16M | 41M | 159M | 19M | |||||
Other Non Operating Income (Expenses) | 253M | 516M | 873M | 654M | 355M | |||||
EBT, Excl. Unusual Items | 289M | -4.44B | -2.18B | 1.36B | 2.15B | |||||
Gain (Loss) On Sale Of Investments | - | 237M | 159M | -8M | 3M | |||||
Gain (Loss) On Sale Of Assets | -53M | 1.01B | 1.58B | 1.04B | -46M | |||||
Asset Writedown | -16M | -54M | -181M | -80M | -88M | |||||
Other Unusual Items | - | -2M | -308M | -1M | -1M | |||||
EBT, Incl. Unusual Items | 220M | -3.24B | -927M | 2.31B | 2.02B | |||||
Income Tax Expense | 283M | 115M | 434M | 698M | 66M | |||||
Earnings From Continuing Operations | -63M | -3.36B | -1.36B | 1.61B | 1.95B | |||||
Net Income to Company | -63M | -3.36B | -1.36B | 1.61B | 1.95B | |||||
Minority Interest | 57M | 199M | 112M | 76M | -6M | |||||
Net Income - (IS) | -6M | -3.16B | -1.25B | 1.69B | 1.94B | |||||
Net Income to Common Incl Extra Items | -6M | -3.16B | -1.25B | 1.69B | 1.94B | |||||
Net Income to Common Excl. Extra Items | -6M | -3.16B | -1.25B | 1.69B | 1.94B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -1.58 | -833.31 | -329.36 | 446.9 | 514.75 | |||||
Basic EPS - Continuing Operations | -1.58 | -833.31 | -329.36 | 446.9 | 514.75 | |||||
Basic Weighted Average Shares Outstanding | 3.81M | 3.79M | 3.79M | 3.78M | 3.78M | |||||
Net EPS - Diluted | -1.58 | -833.31 | -329.36 | 446.9 | 514.75 | |||||
Diluted EPS - Continuing Operations | -1.58 | -833.31 | -329.36 | 446.9 | 514.75 | |||||
Diluted Weighted Average Shares Outstanding | 3.81M | 3.79M | 3.79M | 3.78M | 3.78M | |||||
Normalized Basic EPS | 62.43 | -679.19 | -329.43 | 244.66 | 353.88 | |||||
Normalized Diluted EPS | 62.43 | -679.19 | -329.43 | 244.66 | 353.88 | |||||
Dividend Per Share | 50 | - | - | 10 | 40 | |||||
Payout Ratio | -3.23K | -3.07 | - | - | 4.99 | |||||
Supplemental Items | ||||||||||
EBITDA | 1.84B | -3.01B | -1.35B | 2.06B | 3.1B | |||||
EBITA | 210M | -4.74B | -2.91B | 666M | 1.82B | |||||
EBIT | 210M | -4.74B | -2.91B | 666M | 1.82B | |||||
Effective Tax Rate - (Ratio) | 128.64 | -3.55 | -46.82 | 30.22 | 3.27 | |||||
Normalized Net Income | 238M | -2.57B | -1.25B | 924M | 1.34B | |||||
Non-Cash Pension Expense | 216M | 121M | -102M | 148M | 85M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 860M | 722M | 447M | 128M | 140M | |||||
General and Administrative Expenses | 361M | 341M | 318M | 270M | 255M | |||||
Research And Development Expense From Footnotes | 57M | 53M | 50M | 51M | 53M |